Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Katia Jarquín-YáñezLaboratory of Immunotherapy and Tissue Engineering, Department of Cellular and Tissue Biology, Faculty of Medicine, National Autonomous University of Mexico (UNAM), Av. Universidad 3000, Copilco Universidad, Coyoacán, Ciudad de México 04510, Mexico.ORCID 0000-0003-0086-5728
Diana Michel Aguilar-SandovalLaboratory of Immunotherapy and Tissue Engineering, Department of Cellular and Tissue Biology, Faculty of Medicine, National Autonomous University of Mexico (UNAM), Av. Universidad 3000, Copilco Universidad, Coyoacán, Ciudad de México 04510, Mexico.ORCID 0009-0008-8100-3700
Gabriela Piñón-ZárateLaboratory of Immunotherapy and Tissue Engineering, Department of Cellular and Tissue Biology, Faculty of Medicine, National Autonomous University of Mexico (UNAM), Av. Universidad 3000, Copilco Universidad, Coyoacán, Ciudad de México 04510, Mexico.ORCID 0000-0002-3080-9703
Miguel Angel Herrera-EnríquezLaboratory of Immunotherapy and Tissue Engineering, Department of Cellular and Tissue Biology, Faculty of Medicine, National Autonomous University of Mexico (UNAM), Av. Universidad 3000, Copilco Universidad, Coyoacán, Ciudad de México 04510, Mexico.ORCID 0000-0003-3939-3254
Ivan Daniel Avila-CamposLaboratory of Immunotherapy and Tissue Engineering, Department of Cellular and Tissue Biology, Faculty of Medicine, National Autonomous University of Mexico (UNAM), Av. Universidad 3000, Copilco Universidad, Coyoacán, Ciudad de México 04510, Mexico.
Beatriz Hernandez-TellezLaboratory of Immunotherapy and Tissue Engineering, Department of Cellular and Tissue Biology, Faculty of Medicine, National Autonomous University of Mexico (UNAM), Av. Universidad 3000, Copilco Universidad, Coyoacán, Ciudad de México 04510, Mexico.ORCID 0000-0001-5463-9705
Dayana Mayte Dominguez-DiazLaboratory of Immunotherapy and Tissue Engineering, Department of Cellular and Tissue Biology, Faculty of Medicine, National Autonomous University of Mexico (UNAM), Av. Universidad 3000, Copilco Universidad, Coyoacán, Ciudad de México 04510, Mexico.
Blanca Esther Blancas-LucianoDepartment of Microbiology and Parasitology, Faculty of Medicine, National Autonomous University of Mexico (UNAM), Ciudad de México 04510, Mexico.ORCID 0000-0002-6985-1378
Andrés Eliú Castell-RodríguezLaboratory of Immunotherapy and Tissue Engineering, Department of Cellular and Tissue Biology, Faculty of Medicine, National Autonomous University of Mexico (UNAM), Av. Universidad 3000, Copilco Universidad, Coyoacán, Ciudad de México 04510, Mexico.ORCID 0000-0003-2881-2759
Funding
PAPIIT, DGAPA-UNAM IN216723; IA203025; IT200525Secretaría de Ciencia, Humanidades, Tecnología e Innovación CF-2023-I-2388
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Growth Factor-Primed WJ-MSC Secretome Enhances Fibroblast Expansion In Vitro. · full record | OpenQuestion